The first medication approved by the FDA to treat CTX, a rare lipid storage condition, is Ctexli.
Healthcare & Pharmaceuticals
A study team headed by Gernot Längst (University of Regensburg) and Markus Meißner (LMU Munich) has made significant progress in understanding the gene regulation of the malaria pathogen.
The U.S. Food and Drug Administration (FDA) has approved GOMEKLI™ (mirdametinib), SpringWorks Therapeutics, Inc.’s MEK inhibitor, for the treatment of adult and pediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) that are not amenable to complete resection. SpringWorks Therapeutics, Inc. is a commercial-stage biopharmaceutical company […]
Rapid weight reduction might raise the risk of osteoporosis and reduce muscular mass. However, there is now excellent news for those who may be at danger when taking weight loss medications. According to a recent study from Aarhus University, the adverse effects can be mitigated by the medication bimagrumab.
PD-1 inhibitors and other immune checkpoint inhibitors can be used to treat dozens of different forms of cancer.
This finding clarifies how microenvironments and cellular contacts influence the location-specific adaptation of tissue-resident memory CD8 T cells
The combination immunotherapy affected distant metastases in addition to the treated tumors. It increased the sensitivity of melanomas to checkpoint inhibitors and decreased the creation of new metastases, hence reducing malignant relapses.
Researchers used a cross-vaccination strategy in the trial, which involved 33 healthy adult volunteers between the ages of 21 and 45.
The work explains how lipocartilage cells form and preserve their own lipid reservoirs while maintaining a consistent size.
Scientists created new medications to suppress PD-1 and activate the body’s immune system to combat cancer after its discovery.
